Hospital Repeatedly Double-Booked Surgeries
Federal lawsuit is alleging that Massachusetts General Hospital juggled multiple surgeries and kept patients under anesthesia longer than was safe. According to The Boston Globe, the lawsuit claims that at least 5 surgeons endangered patients in this way and the whistleblower, a former anesthesiologist, witnessed surgeons going back and forth between operating rooms to perform simultaneous operations. When patients stay under anesthesia longer than necessary, it increases the risk of complications.
Some Counties Will Have No ACA Insurer in 2018
There will be 45 counties with no insurer participating in their Affordable Care Act marketplaces in 2018, affecting about 35,000 people. An analysis from The New York Times found that an additional 1388 counties could have just 1 insurer, affecting about 3 million people. The places of the country that will be hardest hit are the South and the Midwest. However, some insurance companies have yet to make a decision about what they will do in 2018 and the final numbers could change. For instance, Anthem has already pulled out of Ohio, but it hasn’t decided about the 299 counties outside of Ohio where it is currently the only insurer.
Congressional Hearing on Drug Prices
The US Senate Committee on Health, Education, Labor, and Pensions will hold a hearing on Tuesday about how America’s drug-delivery system impacts what patients pay. The hearing will explore how industry practices, such as rebates, affect total drug spending, according to The Wall Street Journal. There will be no company executives or industry lobby groups represented at the hearing.
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More